EXTRACORPOREAL BLOOD TREATMENT APPARATUS AND METHOD FOR MONITORING PRESSURES IN AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS
20210379266 · 2021-12-09
Inventors
Cpc classification
A61M1/3653
HUMAN NECESSITIES
A61M1/3623
HUMAN NECESSITIES
International classification
Abstract
An extracorporeal blood treatment apparatus, comprises: at least a pressure sensor (24,25) located in a respective measurement site on an extracorporeal blood circuit (6, 7); an electronic control unit (23) operatively connected at least to the pressure sensor (24, 25). The electronic control unit (23) is configured to perform at least the following procedure: receiving from the pressure sensor (24, 25) a signal correlated to a measured blood pressure (P1measured, P2measured) in the measurement site; correcting the blood measured pressure (P1measured, P2measured) through a mathematical correction model to obtain a blood actual pressure (Pinlet, Poutlet) in a reference site other than the measurement site. Between the reference site and the measurement site, a circuit section and, optionally, at least one additional device (18, 27, 28) is/are positioned. The mathematical correction model is a model of a pressure drop in the circuit section and, optionally, in the additional device (18, 27, 28).
Claims
1-32. (canceled)
33. Extracorporeal blood treatment apparatus, comprising: a blood treatment device; an extracorporeal blood circuit coupled to the blood treatment device and comprising a blood withdrawal line connected to a blood inlet port of the blood treatment device and blood return line connected to a blood outlet port of the blood treatment device; a blood pump, wherein a pump section of the extracorporeal blood circuit is configured to be coupled to the blood pump; a first pressure sensor located in a first measurement site on the on the blood withdrawal line upstream of the blood treatment device; a second pressure sensor located in a second measurement site on the blood return line downstream of the blood treatment device; an electronic control unit operatively connected to the first pressure sensor and to the second pressure sensor, wherein the electronic control unit is configured to: receive, from the first pressure sensor, a signal correlated to a measured blood pressure in the first measurement site; receive, from the second pressure sensor, a signal correlated to a measured blood pressure in the second measurement site; and correct the measured blood pressure of at least one of: the first pressure sensor through a mathematical correction model to obtain an actual blood pressure in a first reference site other than the first measurement site, wherein a first circuit section is positioned between the first reference site and the first measurement site, and the mathematical correction model is a model of at least one pressure drop in the first circuit section; and the second pressure sensor through a mathematical correction model to obtain an actual blood pressure in a second reference site other than the second measurement site, wherein a second circuit section is positioned between the second reference site and the second measurement site, and the mathematical correction model is a model of at least one pressure drop in the second circuit section.
34. Apparatus according to claim 33, wherein between the first reference site and the first measurement site, a first additional device is positioned, wherein determining a pressure drop is achieved through a mathematical correction model of a pressure drop in the first circuit section and in the first additional device.
35. Apparatus according to claim 34, wherein the first additional device comprises one or more of the blood pump, a drip chamber, and line connectors.
36. Apparatus according to claim 33, wherein between the second reference site and the second measurement site, a second additional device is positioned, wherein determining a pressure drop is achieved through a mathematical correction model of a pressure drop in the second circuit section and in the second additional device.
37. Apparatus according to claim 36, wherein the second additional device comprises one or more of a blood warming device, a gas exchanger, line connectors, a drip chamber, and an additional blood treatment device.
38. Apparatus according to claim 33, wherein the first measurement site is at the blood inlet port of the blood treatment device and the second measurement site is at the blood outlet port of the blood treatment device.
39. Apparatus according to claim 33, wherein the electronic control unit is configured to calculate an actual pressure drop of the blood treatment device as a difference between the actual blood pressure in the first reference site and the actual blood pressure in the second reference site.
40. Apparatus according to claim 33, wherein the blood treatment device comprises a blood chamber and a fluid chamber separated from one another by a semipermeable membrane, the apparatus further comprising: a treatment fluid circuit including an effluent line connected with a fluid outlet port of the fluid chamber and configured to receive a filtered waste fluid through the semipermeable membrane, and an effluent pressure sensor placed on the effluent line; wherein the blood chamber comprises the blood inlet port and the blood outlet port and the electronic control unit is configured to: receive, from the effluent pressure sensor, a signal correlated to a filtered waste fluid pressure, calculate an actual access trans-membrane pressure of the blood treatment device as a difference between the actual blood pressure in the first reference site and the filtered waste fluid pressure.
41. Apparatus according to claim 40, wherein the electronic control unit is configured to calculate an actual trans-membrane pressure of the blood treatment device through the formula:
42. Apparatus according to claim 33, comprising a deaeration chamber placed on the blood return line, wherein the second pressure sensor is positioned at the deaeration chamber.
43. Apparatus according to claim 33, wherein the first reference site is closer to the blood treatment device than the first measurement site and the second reference site is closer to the blood treatment device than the second measurement site.
44. Apparatus according to claim 33, wherein the electronic control unit is configured to calculate a trans-membrane pressure of the blood treatment device as a function of the actual blood pressure in the first reference site and/or in the second reference site.
45. Apparatus according to claim 33, wherein the electronic control unit is configured to process the signal correlated to the measured pressure of the blood in the first measurement site to obtain a mean value of the blood pressure in the first measurement site and to process the signal correlated to the measured pressure of the blood in the second measurement site to obtain a mean value of the blood pressure in the second measurement site.
46. Apparatus according to claim 33, wherein the electronic control unit is connected to the blood pump and is configured to: operate the blood pump to generate a variable blood flow comprising a constant flow component of a desired blood flow value and a variable flow component having a nil mean value, the variable blood flow generating at least in the first measurement site and in the second measurement site a pressure progression that is variable in time comprising a pressure component oscillating about a mean value; receive from the first pressure sensor a plurality of pressure values for a time period comprising a plurality of pressure oscillations about the mean value, the pressure values being measured at successive time instants; receive from the second pressure sensor a plurality of pressure values for a time period comprising a plurality of pressure oscillations about the mean value, the pressure values being measured at successive time instants; determine the pressure drop of the mean value of the measured pressure between the first measurement site and the first reference site; determine the pressure drop of the mean value of the measured pressure between the second measurement site and the second reference site; correct the mean value of the measured pressure at the first measurement site using the mathematical correction model; and correct the mean value of the measured pressure at the second measurement site using the mathematical correction model.
47. Apparatus according to claim 33, wherein the mathematical correction model is a function of blood flow rate and a first section geometry in the first circuit section and a second section geometry in the second circuit section.
48. Apparatus according to claim 33, wherein the mathematical correction model is a function of blood flow rate and one of kinematic viscosity or dynamic viscosity of the blood flowing in the first circuit section and one of kinematic viscosity or dynamic viscosity of the blood flowing in the second circuit section.
49. Apparatus according to claim 48, wherein the kinematic viscosity or the dynamic viscosity is estimated through blood temperature and blood protein concentration respectively in the first circuit section and in the second circuit section.
50. Apparatus according to claim 33, wherein the mathematical correction model is an empirical model of a measurement error derived from a plurality of experimental data sets, the measurement error being a difference between the blood measured pressure in the measurement site and the blood actual pressure in the reference site, the mathematical correction model being derived from a regression analysis of the measurement error collected through said plurality of experimental data sets versus one or more parameters including the blood flow rate collected through said plurality of experimental data sets.
51. An extracorporeal blood treatment apparatus, comprising: a blood treatment device comprising a blood chamber and a fluid chamber separated from one another by a semipermeable membrane; an extracorporeal blood circuit coupled to the blood treatment device and comprising a blood withdrawal line connected to a blood inlet port of the blood chamber of the blood treatment device and blood return line connected to a blood outlet port of the blood chamber of the blood treatment device; a blood pump, wherein a pump section of the extracorporeal blood circuit is configured to be coupled to the blood pump; a treatment fluid circuit operatively connected to the extracorporeal blood circuit and comprising an effluent line connected with the fluid outlet port of the fluid chamber to receive a filtered waste fluid through the semipermeable membrane; at least one pressure sensor located at a measurement site on the extracorporeal blood circuit; an electronic control unit operatively connected at least to the pressure sensor and configured to: receive, from the pressure sensor, a signal correlated to a measured pressure in the measurement site; determine a pressure drop between the measurement site and a reference site other than the measurement site, the reference site being a site on the extracorporeal blood circuit, wherein between the reference site and the measurement site, a circuit section and at least one additional device are positioned; and correct the measured pressure in the measurement site based on the determined pressure drop to obtain an actual blood pressure at the measurement site.
52. Apparatus according to previous claim 51, wherein the electronic control unit is configured to determine a pressure drop using a mathematical correction model of a pressure drop in the circuit section and in the additional device.
53. Apparatus according to claim 51, wherein said at least one pressure sensor comprises a first pressure sensor located on the blood withdrawal line upstream of the blood treatment device, wherein the electronic control unit is configured to: receive, from the first pressure sensor, a signal correlated to a first measured blood pressure upstream the blood treatment device; correct the first measured blood pressure using a first mathematical correction model to obtain an actual first blood pressure at the blood inlet port of the blood treatment device.
54. Apparatus according to claim 53, wherein said at least one pressure sensor comprises a second pressure sensor located on the blood return line downstream of the blood treatment device, wherein the electronic control unit is configured to: receive, from the second pressure sensor, a signal correlated to a second measured blood pressure downstream the blood treatment device; correct the second blood measured pressure using a second mathematical correction model to obtain an actual second blood pressure at the blood outlet port of the blood treatment device.
55. Apparatus according to claim 54, wherein the electronic control unit is configured to calculate an actual pressure drop of the blood treatment device as a difference between the actual first blood pressure and the actual second blood pressure.
56. Apparatus according to claim 51, comprising an effluent pressure sensor placed on the effluent line, wherein the electronic control unit is configured to: receive, from the effluent pressure sensor, a signal correlated to a filtered waste fluid pressure, calculate an actual access trans-membrane pressure of the blood treatment device as a difference between the actual blood pressure at the measurement site and the filtered waste fluid pressure.
57. Apparatus according to claim 51, wherein said at least one additional device comprises one or more of a blood warming device, a gas exchanger, line connectors, a drip chamber, and an additional blood treatment device.
58. Apparatus according to claim 51, comprising a deaeration chamber placed on the blood return line, wherein the pressure sensor is positioned at the deaeration chamber and said at least one additional device is placed on the blood return line between the blood treatment device and the deaeration chamber, the reference site being at the blood outlet port of the blood treatment device.
59. Apparatus according to claim 51, wherein the electronic control unit is configured to calculate a trans-membrane pressure of the blood treatment device as a function of a mean value of the measured blood pressure in the measurement site and the determined pressure drop between the measurement site and the reference site.
60. Apparatus according to claim 51, wherein the apparatus comprises an auxiliary pressure sensor located on an auxiliary measuring site either in the extracorporeal blood treatment or in the treatment fluid circuit, wherein the electronic control unit is configured to: receive from the auxiliary pressure sensor a signal correlated to a measured auxiliary pressure in the auxiliary measuring site; correct the auxiliary measured pressure using an auxiliary mathematical correction model to obtain an actual auxiliary pressure in an auxiliary reference site other than the auxiliary measurement site, the auxiliary reference site being on the extracorporeal blood circuit or on the treatment fluid circuit, wherein an auxiliary circuit section is positioned between the auxiliary reference site and the auxiliary measurement site, wherein the auxiliary mathematical correction model is a model of at least an auxiliary pressure drop in the auxiliary circuit; determine an auxiliary pressure drop between the auxiliary measurement site and the auxiliary reference site; and calculate a trans-membrane pressure of the blood treatment device as a function of: the actual blood pressure in the reference site; and either an actual pressure in an auxiliary reference site, or the measured pressure in the auxiliary measurement site.
61. Apparatus according to claim 60, wherein the pressure sensor is located on the blood withdrawal line or on the blood return line and the auxiliary pressure sensor is located on the other of the blood withdrawal line and the blood return line.
62. Apparatus according to claim 60, wherein the pressure sensor is located on the blood withdrawal line or on the blood return line and the auxiliary pressure sensor is located on the treatment fluid circuit.
63. Apparatus according to claim 60, wherein the auxiliary reference site is a reference site located at a venous drip chamber on the blood return line.
Description
DESCRIPTION OF DRAWINGS
[0095] The following drawings relating to aspects of the invention are provided by way of non-limiting example:
[0096]
[0097]
[0098]
[0099]
[0100]
DETAILED DESCRIPTION
[0101] With reference to the appended drawings,
[0102] The blood treatment device 2 has a first compartment or blood chamber 3 and a second compartment or fluid chamber 4 separated from one another by a semipermeable membrane 5. A blood withdrawal line 6 is connected to an inlet port 3a of the blood chamber 3 and is configured, in an operative condition of connection to the patient P, to remove blood from a vascular access device inserted, for example in a fistula on the patient P. A blood return line 7 connected to an outlet port 3b of the blood chamber 3 is configured to receive treated blood from the treatment unit 2 and to return the treated blood, e.g. to a further vascular access also connected to the fistula of the patient P. Note that various configurations for the vascular access device may be envisaged: for example, typical access devices include a needle or catheter inserted into a vascular access which may be a fistula, a graft or a central (e.g. jugular vein) or peripheral vein (femoral vein) and so on.
[0103] The blood withdrawal line 6 and the blood return line 7 are part of an extracorporeal blood circuit of the apparatus 1. The extracorporeal blood circuit 6, 7 and the treatment unit 2 are usually disposable parts which are loaded onto a frame of a blood treatment machine, not shown.
[0104] As shown in
[0105] It should be noted that for the purposes of the present description and the appended claims, the terms “upstream” and “downstream” may be used with reference to the relative positions taken by components belonging to or operating on the extracorporeal blood circuit. These terms are to be understood with reference to a blood flow direction from the first end of the blood withdrawal line 6 connected to the patient P towards the blood chamber 3 and then from the blood chamber 3 towards a second end of the blood return line 7 connected to the vascular access of the patient P.
[0106] The apparatus 1 may further comprise an air trapping device operating on the blood return line 7. The air trapping device may be a venous deaeration chamber 9. The deaeration chamber 9 is placed online in the blood return line 7.
[0107] A first section of the blood return line 7 puts in fluid communication the outlet port 3b of the blood chamber 3 with the deaeration chamber 9 and a second section of the blood return line 7 puts in fluid communication the deaeration chamber 9 with the patient P. The blood coming from the blood chamber 3 of the treatment device 2 enters and exits the deaeration chamber 9 before reaching the patient P.
[0108] An air trapping device may also be present on the blood withdrawal line. Said air trapping device ensures that blood is essentially free of air/air bubbles before entering the blood treatment device 2.
[0109] The apparatus 1 of
[0110] In the example of
[0111] The dialysis line 11, if present, is typically equipped with a dialysis pump and is able to receive a fresh fluid from a module, not shown, for example a bag or on-line preparation section of dialysis fluid, and to send such a fluid to the fluid inlet port 4a of the fluid chamber 4. The effluent line 10, the dialysis line 11 and the fluid chamber 4 are part of a treatment fluid circuit 12. The apparatus 1 as shown in
[0112] The blood warming bag 17 is a substantially flat and soft bag insertable through a slot 19 in a heating seat provided in the blood warming device 18 (
[0113] The blood warming bag 17 presents an inlet 20 and an outlet 21 connected to the extracorporeal blood circuit. For instance, the blood warming bag 17 comprises two sheets of plastic (e.g. polyurethane or polyvinylchloride) superposed and welded to form the bag and to form, inside the bag, a blood warming path 22 delimited by said two sheets and by lines of welding.
[0114] The apparatus 1 further comprises an electronic control unit 23. The electronic control unit 23 may comprise a digital processor (CPU) and memory (or memories), an analog circuit, or a combination thereof, and input/output interfaces. Said control unit 23 is configured to control the apparatus 1 during patient blood treatment through a software stored in the control unit 23. In the embodiment of
[0115] A first pressure sensor 24 is located on the blood withdrawal line 6 upstream the blood treatment device 2 and downstream the blood pump 8. The first pressure sensor 24 may be close to the blood inlet port 3a (the length of tube between the first pressure sensor 24 and the blood inlet port may be only some centimeters) or may be spaced from the blood inlet port (the tube section between the first pressure sensor 24 and the blood inlet port may be decimeters, e.g. 200 mm).
[0116] A second pressure sensor 25 is located on the blood return line 6 downstream the blood treatment device 2. In the embodiment of
[0117] If an air trapping device/deaereation chamber is placed also on the blood withdrawal line 6, the first blood pressure sensor 24 may be placed inside said deaereation chamber.
[0118] The tube sections and possible connectors (e.g. male/female Luer connectors) generate pressure drop in blood flowing through. The blood warming device 18 with the blood warming bag 17 is an additional device which the blood flows through and which generates an additional pressure drop in blood.
[0119] An effluent pressure sensor 26 is also placed on the effluent line 10 to sense pressure of waste fluid. A dialysis pressure sensor 26a might be on the dialysis line 11, in addition to or in lieu of the effluent pressure sensor 26.
[0120] In other embodiments, like the one schematically represented in
[0121] The first pressure sensor 24, the second pressure sensor 25 and the effluent pressure sensor 26 are operatively connected to the electronic control unit 23 to send to said electronic control unit 23 signals correlated to the sensed pressures.
[0122] At least during the treatment, the control unit moves the blood pump to generate a variable flow of blood comprising a constant flow component equal to a desired blood flow value and a variable flow component at substantially zero average value. This is due in particular to the fact that the blood pump is peristaltic in nature and therefore produces a non-constant flow of blood in the circuit, as it is related to the successive squeezing actions of the pump section by the roller/rollers associated to the pump rotor.
[0123] In other words, the hydraulic head of the treated fluid is given by a constriction which runs along the tube. In an example, the pump is constituted by a rotor to which two (or more rollers) are applied, which rotate to “squeeze” the tube and cause the advancement of the fluid. Alternatively linear peristaltic pumps may be used (for example, “finger” pumps) or also other actuators capable of generating a pulsating movement in the blood, i.e. a non-constant flow, but oscillating about an average flow value.
[0124] Alternatively the control unit might control the pump to generate the pulsating movement in the blood in order to use other kinds of pumps which do not have the pressure variations inherently generated. Consequently the variable blood flow generates in the blood circuit a pressure trend that is time-variable P(t) comprising a pressure component ΔP(t) oscillating about an average value P.sub.avg.
[0125] The control unit is programmed to receive, from the pressure sensors located in their respective positions, a plurality of pressure values P.sub.j for a period of time T (typically coinciding with the treatment period). A minimum time period T.sub.min for which the detected pressure data P.sub.j are used, comprises at least one and in particular a plurality of oscillations of the pressure about the average value P.sub.avg; in particular, time periods of 3-7 oscillations are used for each calculation of a mean pressure value used for the TMP calculation as below described.
[0126] Obviously the pressure values P.sub.j are measured in discrete and successive time instants t.sub.1. The sampling timing may be constant, depending on the type of pressure sensor used and possibly other parameters of apparatus operation.
[0127] According to the apparatus and method of the invention, the electronic control unit 23 is configured to receive from the first pressure sensor 24, from the second pressure sensor 25 and from the effluent pressure sensor 26 respective signals correlated to the measured pressures in the respective sites, to correct at least some of the measured pressures and to compute pressure differences useful to monitor the blood treatment process performed by the apparatus 1.
[0128] In order to correct the measured blood pressures, one or more correction mathematical models or algorithms is/are previously developed and stored in a memory of the electronic control unit 23 or connected to the electronic control unit 23. The mathematical correction model/s is/are model/s of pressure drop/s in the circuit section/s and in the additional device/s. Through the mathematical correction model/s, actual pressures in reference sites other than the measurement sites is/are obtained.
[0129] Referring to the embodiment of
[0130] The first correction model takes into account a pressure drop ΔPtL1 caused by the tube section of length L1 (e.g. 200 mm) between the first pressure sensor 24 and the blood inlet port 3a.
Pinlet=P1measured−ΔPtL1 i)
[0131] The first mathematical correction model of the pressure drop ΔPtL1 caused by the tube section may be built from the following physical equation:
ΔPtL1=f1(Qb,H,τ1,ρ,η1) ii)
where
Qb blood flow rate
H blood hematocrit
ρ blood density
ξ1 loss coefficient of tube
η1 kinematic viscosity in tube
[0132] Equation ii) takes also into account the geometry of the tube and connector/s, e.g. male/female Luer connectors. The density of blood may be estimated as a function blood hematocrit and water density ρw.
[0133] The electronic control unit 23 receives from the second pressure sensor 25 a signal correlated to a second measured blood pressure P2measured downstream the blood treatment device 2 and corrects the second blood measured pressure P2measured through a second mathematical correction model to obtain a second blood actual pressure Poutlet at the blood outlet port 3b of the blood treatment device 2.
[0134] The second correction model takes into account a pressure drop ΔPtL2 caused by the tube section of length L2 (e.g. 250 mm) between the blood outlet port 3b and the blood warming device 18, the pressure drop ΔPw caused by the blood warming path 22 of the blood warming bag 17 and the pressure drop ΔPtL3 caused by a tube section of length L3 (e.g. 250 mm) between the blood warming device 18 and the second pressure sensor 25.
Poutlet=P2measured+ΔPtL2+ΔPw+ΔPtL3 iii)
Physical equations for ΔPtL2 and ΔPtL3 are similar to ii).
ΔPtL2=f2(Q,H,ξ2,ρ,η2) iv)
ξ2 loss coefficient of tube
η2 kinematic viscosity in tube
ΔPtL3=f3(Q,H,ξ3,ρ,η3) v)
ξ3 loss coefficient of tube
η3 kinematic viscosity in tube
[0135] Physical equation caused by blood warming bag is:
ΔPw=f4(Q,H,ξ4,ρ,η4) vi)
where
Qb blood flow rate
H blood hematocrit
ρ blood density
ξ4 loss coefficient of bag
η4 kinematic viscosity in bag
[0136] Equation vi) takes also into account the geometry of bag and connector/s. The density of blood may be estimated as a function blood hematocrit and water density ρw.
[0137] The kinematic viscosity description of blood includes the variables shear rate, hematocrit and protein content of blood. For the tube section and bag respectively this gives:
η1=f5(μpl,k1,ρ,H) vii)
n2=f6(μpl,k2,ρ,H) viii)
where
μpl is the dynamic plasma viscosity which may be defined as function of protein content Cp (e.g. albumin or total proteins).
Cp may also be estimated from hematocrit H.
k1, k2 are shear dependent intrinsic viscosity in tube and bag which may be defined as function of hematocrit H. To optimize kinematic viscosity description, blood temperature may also be included.
[0138] Therefore, in order to build physical equations of the correction models (estimating blood pressure drops in different devices/circuit sections) data needed may be:
H hematocrit value
Qb blood flow rate
ρw water density
Cp protein content
Geometry of devices/circuit sections (lengths, diameters, loss coefficients, etc.)
[0139] Blood flow Qb, hematocrit H, temperature and total protein concentration Cp may change in the various sections of the blood circuit according to infusions in the pre- and/or post-infusion lines 13, 14, 15, 16 and/or ultrafiltration in the blood treatment device 2.
[0140] Alternatively, the correction models may be built using a more empirical approach. The mathematical correction model is an empirical model of a measurement error E derived from a plurality of experimental data sets, e.g. gathered during development testing. The measurement error E may be a difference between the blood measured pressure in the measurement site and the blood actual pressure in the reference site.
[0141] The empirical mathematical correction model is built by carrying out a plurality of test treatments. An experimental data set is collected for each test treatment. Each experimental data set comprises a one or more measured parameters.
[0142] The mathematical correction model may be derived from a regression analysis of the measurement error E collected through said plurality of experimental data sets versus the mentioned parameter/s collected through said plurality of experimental data sets. The model will be as reliable as the experimental data set collection is large. Regression model may be streamlined as linear versus blood flow rate Qb.
[0143] The electronic control unit 23 further receives from the effluent pressure sensor 26 a signal correlated to the measured pressure P3m of waste fluid. The effluent pressure sensor 26 is close to the fluid outlet port 4b and the measured pressure of waste fluid P3m may be considered as an actual pressure Peffluent of waste fluid at the outlet port 4b.
[0144] The electronic control unit 23 is programmed to calculate an actual pressure drop DPactual of the blood treatment device 2 as a difference between the first actual blood pressure Pinlet and the second blood actual pressure Poutlet.
DPactual=Pinlet−Poutlet viii)
If no correction of measured pressures were performed, the measured pressure drop DPmeasured of the blood treatment device 2 would be:
Dpmeasured=Dpactual+(ΔPtL1+ΔPtL2+ΔPw+ΔPtL3) ix)
[0145] The measured pressure drop Dpmeasured of the blood treatment device 2 would be overestimated with respect to the actual pressure drop Dpactual of the blood treatment device 2. A difference between the measured pressure drop Dpmeasured and the actual pressure drop Dpactual may be e.g. between 50 mmHg and 200 mmHg.
[0146] The electronic control unit 23 is programmed to calculate an actual trans-membrane pressure TMPactual of the blood treatment device 2 through the formula:
TMPactual=((Pinlet+Poutlet)/2)−Peffluent x)
[0147] If no correction of measured pressures were performed, the measured trans-membrane pressure TMPmeasured would be:
TMPmeasured=TMPactual+((ΔPtL1−(ΔPtL2+ΔPw+ΔPtL3))/2) xi)
[0148] Depending on values of ΔPtL1 and (ΔPtL2+ΔPw+ΔPtL3), the measured trans-membrane pressure TMPmeasured would be overestimated or underestimated with respect to the actual transmembrane pressure TMPactual. A difference between the measured trans-membrane pressure TMPmeasured and the actual trans-membrane pressure TMPactual may be e.g. between +/−10 mmHg and +/−50 mmHg.
[0149] If plasmapheresis is performed, the electronic control unit 23 is programmed to calculate an actual access trans-membrane pressure TMPaactual of the blood treatment device 2 (plasmafilter).
TMPaactual=Pinlet−Peffluent xii)
[0150] If no correction of measured pressures were performed, the measured access trans-membrane pressure TMPameasured would be:
TMPameasured=TMPaactual+ΔPtL1 xiii)
[0151] The measured access trans-membrane pressure TMPameasured would be overestimated with respect to the actual access trans-membrane pressure TMPaactual. A difference between the measured access trans-membrane pressure TMPameasured and the actual access transmembrane pressure TMPaactual may be e.g. between 20 mmHg and 50 mmHg.
[0152] The actual pressure drop (DPactual) and actual transmembrane pressures (TMPactual and TMPaactual) may be monitored for the purpose of diagnosing blood treatment device plugging (excessive filtration), clotting and/or preventing risk of fiber.
[0153] By way of example, the electronic control unit 23 is configured to trigger alarms if the actual pressure drop and/or the transmembrane pressure and/or the access trans-membrane pressure is/are outside respective safe range/s.
[0154] The illustrated example of
[0155] While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiment, it is to be understood that the invention is not to be limited to the disclosed embodiment, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the scope of the appended claims.